Brief: IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study

May 13 (Reuters) - Imunon Inc  IMNN.O :
    * IMUNON ANNOUNCES SITE ACTIVATION FOR IMNN-101 PHASE 1
VACCINE
STUDY
    * IMUNON INC - TOPLINE RESULTS EXPECTED THIS YEAR

Source text for Eikon:  ID:nGNX1hrJjq 
Further company coverage:  IMNN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Imunon

See all news